Malignancy-related mir-210, mir-373 and let-7 levels are affected in iron deficiency anemia

Ruveyda Sak1, Demircan Ozbalci2, Emine Guchan Alanoglu2

  • 1City Hospital of Etlik, Department of Rheumatology.

African Health Sciences
|February 15, 2024
PubMed
Abstract

Insights

Iron deficiency anemia (IDA) is linked to hypoxia, affecting malignancy-related microRNAs (miRNAs). This study found elevated miR-210 and decreased miR-373 and let-7 in IDA patients, suggesting altered miRNA profiles in anemia.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Hematology

Background:

  • Hypoxia is a key feature of iron deficiency anemia (IDA).
  • Malignancy-related microRNAs (miRNAs) show altered expression in hypoxic conditions.
  • Investigating specific miRNAs (miR-210, miR-373, let-7) in IDA is crucial.

Purpose of the Study:

  • To determine differences in plasma levels of miR-210, miR-373, and let-7 in patients with IDA compared to healthy controls.
  • To explore the relationship between these malignancy-associated miRNAs and the hypoxic state in IDA.

Main Methods:

  • A case-control study involving 35 female IDA patients and 10 healthy controls.
  • Exclusion criteria included oral iron therapy, inflammatory disease, and pregnancy.
  • Statistical analysis employed Student t-test, Mann-Whitney U test, and chi-square test.

Main Results:

  • Plasma miR-210 expression was significantly higher in the IDA group (p=0.022).
  • Plasma miR-373 and let-7 expression showed a non-significant down-regulation in IDA patients.
  • Mean hemoglobin and ferritin levels in IDA patients were 10.78±0.93 g/dL and 6.28±5.76 ng/mL, respectively.

Conclusions:

  • Plasma miR-210 is significantly up-regulated in patients with iron deficiency anemia.
  • miR-373 and let-7 expression are down-regulated, though not significantly, in IDA.
  • These findings indicate altered miRNA expression patterns in IDA, potentially linked to hypoxia and malignancy risk.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K